Achondroplasia Clinical Trials
Condition
Location
Distance
Any
<10 miles
<30 miles
<50 miles
<70 miles
Age
Filter Results
Condition
Where are you looking?
How far are you willing to travel?
Any
How old are you?
Trial Status
Recruiting status
Recruiting
Waitlist Available
Placebo
Show Trials Without Placebo
View Trials
TYRA-300 for Achondroplasia
3 - 10
All Sexes
Kissimmee, FL
This trial aims to assess how safe and well-tolerated TYRA-300 is in children with achondroplasia who still have open growth plates, and to determine the most effective dose(s
Phase 2
Recruiting
Has No Placebo
Learn More
Rare Disease Research (+2 Sites)
Doug Warner, MD
Tyra Biosciences, Inc
CGT4859 for Bile Duct Cancer
18+
All Sexes
Palo Alto, CA
This trial is testing a new drug, CGT4859, in adults with a specific type of liver cancer or other advanced solid tumors. The study will look at how safe and tolerable the drug
Phase 1 & 2
Recruiting
Has No Placebo
Learn More
Stanford Cancer Institute (+9 Sites)
Cogent Biosciences, Inc.
Infigratinib for Achondroplasia
3 - 17
All Sexes
San Francisco, CA
This trial tests a drug to help children and teens with achondroplasia. It's randomized, double-blind, and placebo-controlled.
Phase 3
Waitlist Available
Drug
Learn More
QED Investigative Site (+10 Sites)
QED Therapeutics, Inc. Medical Director, Clinical Development
QED Therapeutics, Inc.
View More